The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
Clomiphene citrate—end of an era? a mini-review
Open accessAbstract
The purpose of this review is to examine whether the time has come to replace clomiphene citrate (CC) as the first line therapy for WHO group II (eu-oestrogenic) infertility, the majority of which is associated with polycystic ovary syndrome. CC has been the first line therapy for these cases for the last 40 years. It is a simple, cheap treatment, almost devoid of side effects which yields a single live birth rate of approximately 25% of starters. Non-response to CC and the gap between ovulation and pregnancy rates have variously been attributed to its anti-estrogen effects, and high LH and androgen concentrations. Three possible contenders for the replacement of CC as first-line treatment are scrutinized: metformin, aromatase inhibitors and low-dose FSH. Each has their advantages and disadvantages, but none of them, while showing much potential promise, has been proven, as yet, to be a feasible replacement for CC in this role. For CC, it may not yet be the end of an era but it may be the beginning of the end.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mitwally, M. F. M., & Casper, R. F. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01705-2 · Cited by 800 · cited 2×
“It has been hypothesized, in particular by Mitwally and Casper (2001), that the efficient estrogen-lowering properties of the aromatase inhibitors could be utilized to temporarily release the hypothalamus from the negative feedback effect of estrogen so inducing an increased discharge of FSH.”
BackgroundNestler, J. E., Jakubowicz, D. J., Evans, W. S., & Pasquali, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199806253382603 · Cited by 784
Moghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6293 · Cited by 660
Androgen and follicle stimulating hormone interactions in primate ovarian follicle development
Weil, S., Vendola, K., Zhou, J., & Bondy, C. A. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.8.5929 · Cited by 592
Effects of Metformin on Early Pregnancy Loss in the Polycystic Ovary Syndrome
Jakubowicz, D. J., Iuorno, M. J., Jakubowicz, S., Roberts, K. A., & Nestler, J. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8207 · Cited by 492
Hypersecretion of luteinising hormone, infertility, and miscarriage
Regan, L., Owen, E. J., & Jacobs, H. S. (1990) · The Lancet · doi:10.1016/0140-6736(90)92765-a · Cited by 450
Homburg, R., Armar, N. A., Eshel, A., Adams, J., & Jacobs, H. S. (1988) · BMJ · doi:10.1136/bmj.297.6655.1024 · Cited by 436
Self-citationAromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders
Mitwally, M. F. M., & Casper, R. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)03280-0 · Cited by 407
Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin
Glueck, C. J., Wang, P., Goldenberg, N., & Sieve-Smith, L. (2002) · Human Reproduction · doi:10.1093/humrep/17.11.2858 · Cited by 385
Tang, T., Norman, R. J., Balen, A. H., & Lord, J. M. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003053 · Cited by 369
Fleming, R. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.569 · Cited by 368
Vandermolen, D. T., Ratts, V. S., Evans, W. S., Stovall, D. W., Kauma, S. W., & Nestler, J. E. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(00)01675-7 · Cited by 356
Fisher, S. A., Reid, R. L., Van Vugt, D. A., & Casper, R. F. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03241-7 · Cited by 347 · cited 1×
“A direct comparison of letrozole with 50mg/day of CC in ovulatory women in an RCT showed similar effects on stimulation of folliculogenesis, whilst endometrial thickness was maintained by letrozole despite much lower estradiol concentrations than with CC at mid-cycle (Fisher et al., 2002).”
BackgroundInduction of Ovulation with MRL/41: Preliminary Report
Greenblatt, R. B. (1961) · JAMA · doi:10.1001/jama.1961.03040410001001 · Cited by 343
Modern use of clomiphene citrate in induction of ovulation
Kousta, E. (1997) · Human Reproduction Update · doi:10.1093/humupd/3.4.359 · Cited by 333
Menstrual Cyclicity After Metformin Therapy in Polycystic Ovary Syndrome
M, E., ACOSTA, A., & MENDOZA, S. (1997) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(97)00296-2 · Cited by 311
Baillargeon, J.-P., Jakubowicz, D. J., Iuorno, M. J., Jakubowicz, S., & Nestler, J. E. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.02.127 · Cited by 300 · cited 3×
“In women with PCOS but normal insulin sensitivity, metformin proved more efficient than rosiglitazone in restoring ovulation (Baillargeon et al., 2004).”
BackgroundEfficacy of treatment for unexplained infertility
Guzick, D., Sullivan, M., Adamson, G. D., Cedars, M., Falk, R., Peterson, E., & Steinkampf, M. (1998) · Fertility and Sterility · doi:10.1016/s0015-0282(98)00177-0 · Cited by 289
Gysler, M., March, C. M., Mishell, D. R., & Bailey, E. J. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46033-4 · Cited by 270
Imani, B., Eijkemans, M. J. C., te Velde, E. R., Habbema, J. D. F., & Fauser, B. C. J. M. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02929-6 · Cited by 262 · cited 1×
“Although it is virtually impossible to predict who will respond to which dose of CC, if at all (Imani et al., 2002), body weight has been found to be an impeding factor.”
BackgroundImani, B., Eijkemans, M. J. C., te Velde, E. R., Habbema, J. D. F., & Fauser, B. C. J. M. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.7.4919 · Cited by 262
Metformin directly inhibits androgen production in human thecal cells
Attia, G. R., Rainey, W. E., & Carr, B. R. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01975-6 · Cited by 256
Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome
Harborne, L., Fleming, R., Lyall, H., Norman, J., & Sattar, N. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13493-9 · Cited by 256
Clomiphene citrate versus letrozole for ovarian stimulation: a pilot study
Fatemi, H. M., Kolibianakis, E., Tournaye, H., Camus, M., Van Steirteghem, A., & Devroey, P. (2003) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)62070-6 · Cited by 253
Metformin has direct effects on human ovarian steroidogenesis
Mansfield, R., Galea, R., Brincat, M., Hole, D., & Mason, H. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04925-7 · Cited by 237
Garcia, J., Jones, G. S., & Wentz, A. C. (1977) · Fertility and Sterility · doi:10.1016/s0015-0282(16)42670-1 · Cited by 233
Nestler, J. E., Stovall, D., Akhter, N., Iuorno, M. J., & Jakubowicz, D. J. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(01)02963-6 · Cited by 230
Homburg, R. (1999) · Human Reproduction Update · doi:10.1093/humupd/5.5.493 · Cited by 187
Self-citationImani, B. (1998) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.83.7.2361 · Cited by 187
Ghazeeri, G., Kutteh, W. H., Bryer-Ash, M., Haas, D., & Ke, R. W. (2003) · Fertility and Sterility · doi:10.1016/s0015-0282(02)04843-4 · Cited by 182
Further Clinical Experience with Clomiphene Citrate
Macgregor, A. H., Johnson, J. E., & Bunde, C. A. (1968) · Fertility and Sterility · doi:10.1016/s0015-0282(16)36736-x · Cited by 169
Multiple pregnancies following induction of ovulation
Wallach, E. E., Schenker, J. G., Yarkoni, S., & Granat, M. (1981) · Fertility and Sterility · doi:10.1016/s0015-0282(16)45308-2 · Cited by 164
Sensitization to Insulin Induces Ovulation in Nonobese Adolescents with Anovulatory Hyperandrogenism
Ibáñez, L., Valls, C., Ferrer, A., Marcos, M. V., Rodriguez-Hierro, F., & de Zegher, F. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.8.7756 · Cited by 162
Clinical and laboratory predictors of clomiphene response
Løbo, R. A., Gysler, M., March, C. M., Goebelsmann, U., & Mishell, D. R. (1982) · Fertility and Sterility · doi:10.1016/s0015-0282(16)46034-6 · Cited by 147
Insulin-sensitizing agents as primary therapy for patients with polycystic ovarian syndrome
Kashyap, S., Wells, G. A., & Rosenwaks, Z. (2004) · Human Reproduction · doi:10.1093/humrep/deh440 · Cited by 143
Healey, S., Tan, S. L., Tulandi, T., & Biljan, M. M. (2003) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.03.001 · Cited by 132 · cited 1×
“These preliminary findings were confirmed in a large series, albeit retrospective and non-randomized, comparing stimulation with FSH alone (145 cycles) or the combined therapy (60 cycles) (Healey et al., 2003).”
ResultA randomized study of dexamethasone in ovulation induction with clomiphene citrate
Daly, D. C., Walters, C. A., Soto-Albors, C. E., Tohan, N., & Riddick, D. H. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)47896-9 · Cited by 129
Aromatase inhibitors for the treatment of infertility
Mitwally, M. F., & Casper, R. F. (2003) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.12.3.353 · Cited by 122
POLSON, D. W., Mason, H. D., SALDAHNA, M. B. Y., & Franks, S. (1987) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1987.tb00778.x · Cited by 119
High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome
Brosens, J. J., Verhoeven, H., Campo, R., Gianaroli, L., Gordts, S., Hazekamp, J., Hägglund, L., Mardesic, T., Varila, E., Zech, J., et al. (2004) · Human Reproduction · doi:10.1093/humrep/deh075 · Cited by 119
Homburg, R., Eshel, A., Armar, N. A., Tucker, M., Mason, P. W., Adams, J. M., Kilborn, J., Sutherland, I. A., & Jacobs, H. S. (1989) · BMJ · doi:10.1136/bmj.298.6676.809 · Cited by 104
Self-citationThe effect of therapy initiation day on clomiphene citrate therapy
Wu, C., & Winkel, C. A. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60964-0 · Cited by 100
POLSON, D. W., Kiddy, D. S., Mason, H. D., & Franks, S. (1989) · Fertility and Sterility · doi:10.1016/s0015-0282(16)60423-5 · Cited by 92
HORMONAL PROFILES FOLLOWING CLOMIPHENE CITRATE THERAPY IN CONCEPTION AND NONCONCEPTION CYCLES
Shoham, Z., Borenstein, R., Lunenfeld, B., & Pariente, C. (1990) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1990.tb00491.x · Cited by 87
Ovulation induction in perspective
Homburg, R., & Insler, V. (2002) · Human Reproduction Update · doi:10.1093/humupd/8.5.449 · Cited by 83
Self-citationGeorge, S. S. (2003) · Human Reproduction · doi:10.1093/humrep/deg105 · Cited by 79
Infertility: Incidence of spontaneous abortion in clomiphene pregnancies
Dickey, R. P., Taylor, S. N., Curole, D. N., Rye, P. H., & Pyrzak, R. (1996) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a019182 · Cited by 76
Gestational Outcome of Clomiphene-Related Conceptions
Adashi, E. Y., Rock, J. A., Sapp, K. C., Martin, E. J., Wentz, A. C., & Jones, G. S. (1979) · Fertility and Sterility · doi:10.1016/s0015-0282(16)44051-3 · Cited by 76
Outcome of Pregnancy After Clomiphene Therapy
Åhlgren, M., Källén, B. A. J., & Rannevik, G. (1976) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347609158516 · Cited by 75
Relationship of clomiphene dose and patient weight to successful treatment
Dickey, R. P., Taylor, S. N., Curole, D. N., Rye, P. H., Lu, P. Y., & Pyrzak, R. (1997) · Human Reproduction · doi:10.1093/humrep/12.3.449 · Cited by 73
The reproductive toxicity of ovulation induction
Wallach, E. E., & Scialli, A. R. (1986) · Fertility and Sterility · doi:10.1016/s0015-0282(16)49209-5 · Cited by 60
Monitoring techniques for improved pregnancy rates during clomiphene ovulation induction
Wallach, E. E., & Hammond, M. G. (1984) · Fertility and Sterility · doi:10.1016/s0015-0282(16)48129-x · Cited by 60
Monitoring plasma concentrations to individualize treatment with clomiphene citrate
Rostami‐Hodjegan, A., Lennard, M. S., Tucker, G. T., & Ledger, W. J. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.07.044 · Cited by 57
López, E., Joanne, G., Daya, S., Daya, S., Parrilla, J. J., Abad, L., Balasch, J., & Balasch, J. (2004) · Reproductive BioMedicine Online · doi:10.1016/s1472-6483(10)61273-4 · Cited by 52
The outcome of pregnancy resulting from clomiphene-induced ovulation
Correy, J. F., Marsden, D. E., & Schokman, F. C. M. (1982) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.1982.tb01391.x · Cited by 47
Homburg, R. (2002) · Human Reproduction · doi:10.1093/humrep/17.4.853 · Cited by 45
Self-citationAgarwal, S. K., & Buyalos, R. P. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a135937 · Cited by 41
Biljan, M. M., Tan, S. L., & Tulandi, T. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03524-0 · Cited by 23
de Ziegler, D. (2003) · Human Reproduction · doi:10.1093/humrep/deg310 · Cited by 22
Eijkemans, M. J. C., Habbema, J. D. F., & Fauser, B. C. J. M. (2003) · Seminars in Reproductive Medicine · doi:10.1055/s-2003-39993 · Cited by 14
Cited by
Consensus on infertility treatment related to polycystic ovary syndrome
(2008) · Fertility and Sterility · doi:10.1016/j.fertnstert.2007.09.041 · Cited by 730
Balen, A. H., Morley, L. C., Misso, M., Franks, S., Legro, R. S., Wijeyaratne, C. N., Stener-Victorin, E., Fauser, B. C. J. M., Norman, R. J., & Teede, H. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw025 · Cited by 705
Treatment options for polycystic ovary syndrome
Badawy, A., & Elnashar (2011) · International Journal of Women's Health · doi:10.2147/ijwh.s11304 · Cited by 619
Mucosal Applications of Poloxamer 407-Based Hydrogels: An Overview
Giuliano, E., Paolino, D., Fresta, M., & Cosco, D. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030159 · Cited by 368
Karimzadeh, M. A., & Javedani, M. (2010) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.02.078 · Cited by 118
Metadata
- Authors
- Homburg, R.
- Venue
- Human Reproduction
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-05-05
- Volume
- 20
- Issue
- 8
- Pages
- 2043-2051
- ISSN
- 0268-1161 (ISSN-L)
- 1460-2350
- OpenAlex
- W2156993772
- Cited by
- 331
- References
- 60
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.